bf/NYSE:AMRX_icon.png

NYSE:AMRX

Amneal Pharmaceuticals

  • Stock

7.74

+1.04%

−0.08

USD last updated 01/08 02:13:39

Last Close

7.82

31/07 20:14

Market Cap

2.19B

Beta: 1.32

Volume Today

3.12M

Avg: 1.09M

PE Ratio

151.43

PFCF: 12.36

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, in...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    0.10.20.30.42016-11-092018-08-092020-08-062022-08-052024-08-02

    Revenue (Estimate*)

    200M400M600M800M1B1.20B1.40B2016-11-092018-08-092020-08-062022-08-052024-08-02

    *Estimate based on analyst consensus